{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:20:41Z","timestamp":1790796041886,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["04\/04498-4"],"award-info":[{"award-number":["04\/04498-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bcmd.2014.12.004","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T16:47:25Z","timestamp":1419612445000},"page":"244-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Interleukin-1\u03b2 and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia"],"prefix":"10.1016","volume":"54","author":[{"given":"Perla","family":"Vicari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Adegoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Robles","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Delfini","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Eiko","family":"Nogutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","article-title":"Predicting clinical severity in sickle cell anaemia","volume":"129","author":"Steinberg","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.12.004_bb0010","series-title":"Sickle Cell Disease. Basic Principles and clinical practice","first-page":"195","article-title":"Erythocyte density heterogeneity","author":"Mohandas","year":"1994"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0037-1963(01)90023-X","article-title":"Pathophysiology of sickle cell disease: role of cellular and genetic modifiers","volume":"38","author":"Steinberg","year":"2001","journal-title":"Semin. Hematol."},{"issue":"11","key":"10.1016\/j.bcmd.2014.12.004_bb0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcmd.2014.12.004_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/10245330310001604719","article-title":"Cytokines in sickle cell disease","volume":"8","author":"Pathare","year":"2003","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.bcmd.2014.12.004_bb0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOH.0b013e3282a4a673","article-title":"Cytokines and plasma factors in sickle cell disease","volume":"14","author":"Brittain","year":"2007","journal-title":"Curr. Opin. Hematol."},{"issue":"11","key":"10.1016\/j.bcmd.2014.12.004_bb0040","doi-asserted-by":"crossref","first-page":"e7956","DOI":"10.1371\/journal.pone.0007956","article-title":"Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease","volume":"4","author":"Niu","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00007890-200108270-00027","article-title":"Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6","volume":"72","author":"Cox","year":"2001","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bcmd.2014.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bcmd.2014.12.004_bb0055","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/hq0901.094280","article-title":"Interleukin-6 gene \u2212174g>c and \u2212572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery","volume":"21","author":"Brull","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/01.ATV.0000013283.84306.1A","article-title":"Interleukin-6\u2013174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS)","volume":"22","author":"Basso","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5223(03)00396-9","article-title":"Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery","volume":"126","author":"Gaudino","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.bcmd.2014.12.004_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.imlet.2004.08.015","article-title":"IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma","volume":"96","author":"Mazur","year":"2005","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/hmg\/ddi469","article-title":"Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context","volume":"15","author":"Chen","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcmd.2014.12.004_bb0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2007.06560.x","article-title":"Genetic polymorphisms associated with priapism in sickle cell disease","volume":"137","author":"Elliott","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bcmd.2014.12.004_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0888-7543(88)90152-8","article-title":"The human \u201cinterferon-beta 2\/hepatocyte stimulating factor\/interleukin-6\u201d gene: DNA polymorphism studies and localization to chromosome 7p21","volume":"3","author":"Bowcock","year":"1988","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.bcmd.2014.12.004_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO;2-Q","article-title":"The biological effects of interleukin 6","volume":"16","author":"Barton","year":"1996","journal-title":"Med. Res. Rev."},{"issue":"2\u20133","key":"10.1016\/j.bcmd.2014.12.004_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1744-313X.1998.tb01147.x","article-title":"A novel NlaIII polymorphism in the human IL-6 promoter","volume":"25","author":"Olomolaiye","year":"1998","journal-title":"Eur. J. Immunogenet."},{"issue":"24","key":"10.1016\/j.bcmd.2014.12.004_bb0100","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation","volume":"275","author":"Terry","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcmd.2014.12.004_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00024382-200309000-00004","article-title":"Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses","volume":"20","author":"Rivera-Chavez","year":"2003","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000204452","article-title":"Levels of tumor necrosis factor alpha\/cachectin (TNF alpha) in sera from patients with sickle cell disease","volume":"90","author":"Malave","year":"1993","journal-title":"Acta Haematol."},{"issue":"9","key":"10.1016\/j.bcmd.2014.12.004_bb0115","first-page":"609","article-title":"Tumor necrosis factor alpha in children with sickle cell disease in stable condition","volume":"89","author":"Kuvibidila","year":"1997","journal-title":"J. Natl. Med. Assoc."},{"issue":"9","key":"10.1016\/j.bcmd.2014.12.004_bb0120","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V92.9.3148","article-title":"Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis","volume":"92","author":"Michaels","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bcmd.2014.12.004_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1590\/S0100-879X2001001000011","article-title":"Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease","volume":"34","author":"Goncalves","year":"2001","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.bcmd.2014.12.004_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/153537020523000109","article-title":"Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease","volume":"230","author":"Hibbert","year":"2005","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"2","key":"10.1016\/j.bcmd.2014.12.004_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.bcmd.2014.12.004_bb0140","first-page":"863","article-title":"Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8","volume":"89","author":"Etienne-Julan","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000046509","article-title":"Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients","volume":"104","author":"Makis","year":"2000","journal-title":"Acta Haematol."},{"issue":"11","key":"10.1016\/j.bcmd.2014.12.004_bb0150","first-page":"753","article-title":"Type 2 cytokine serum levels in healthy sickle cell disease patients","volume":"89","author":"Taylor","year":"1997","journal-title":"J. Natl. Med. Assoc."},{"issue":"6","key":"10.1016\/j.bcmd.2014.12.004_bb0155","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcmd.2014.12.004_bb0160","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"Confirmation of an association between the TNF(\u2212308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.bcmd.2014.12.004_bb0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000321935","article-title":"Absence of association between TNF-alpha polymorphism and cerebral large-vessel abnormalities in adults with sickle cell anemia","volume":"125","author":"Vicari","year":"2011","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2014.12.004_bb0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cyto.2011.07.002","article-title":"TNF-alpha and IL-8: serum levels and gene polymorphisms (\u2212308G>A and \u2212251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia","volume":"56","author":"Cajado","year":"2011","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.bcmd.2014.12.004_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.gene.6363766","article-title":"IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels","volume":"2","author":"Buchs","year":"2001","journal-title":"Genes Immunol."},{"issue":"2","key":"10.1016\/j.bcmd.2014.12.004_bb0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.bcmd.2014.12.004_bb0185","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.bcmd.2014.12.004_bb0190","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcmd.2014.12.004_bb0195","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1beta as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bcmd.2014.12.004_bb0200","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.V63.6.1353.1353","article-title":"Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia","volume":"63","author":"Steinberg","year":"1984","journal-title":"Blood"},{"issue":"7\u20138","key":"10.1016\/j.bcmd.2014.12.004_bb0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/03630268908998842","article-title":"The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia","volume":"13","author":"Ballas","year":"1989","journal-title":"Hemoglobin"},{"issue":"5","key":"10.1016\/j.bcmd.2014.12.004_bb0210","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.hoc.2005.07.001","article-title":"Bone and joint disease in sickle cell disease","volume":"19","author":"Aguilar","year":"2005","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.bcmd.2014.12.004_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"issue":"2","key":"10.1016\/j.bcmd.2014.12.004_bb0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2013.10.009","article-title":"Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype","volume":"65","author":"Bandeira","year":"2014","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bcmd.2014.12.004_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","article-title":"Cytokine gene polymorphism in human disease: on-line databases","volume":"1","author":"Bidwell","year":"1999","journal-title":"Genes Immunol."}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2015.02.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:45:05Z","timestamp":1598615105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1079979614001600"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.12.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcmd.2015.02.002","asserted-by":"object"}]},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-1\u03b2 and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}